TransMedics Group, Inc.
TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditā¦ read more
Healthcare
Medical Devices
6 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$119.17
Price-4.65%
-$5.81
1Y
Price
Market Cap
$4.073b
Mid
Price/Earnings 3y Avg5y Avg
46.9x
Premium
Premium
Financials Overview
Key metrics over the past few years+29.5%
EBITDA Margin+22.2%
Net Profit Margin+52.5%
Free Cash Flow MarginRevenue
$531.292m
+20.3%
1y CAGR+87.2%
3y CAGR+117.6%
5y CAGREarnings
$71.662m
+102.1%
1y CAGR+124.9%
3y CAGR+98.2%
5y CAGREPS
$1.93
+91.1%
1y CAGR+119.9%
3y CAGR+95.7%
5y CAGRBook Value
$318.101m
$890.522m
Assets$572.421m
Liabilities$518.822m
DebtDebt to Assets
58.3%
4.6x
Debt to EBITDAFree Cash Flow
$17.352m
+121.4%
1y CAGR-17.8%
3y CAGR-32.9%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company